TOP STORIES

• REGULATORY Post-Launch Re-Pricing Likely the Focus of Chuikyo Leqembi Discussions
  October 5, 2023

• ORGANIZATION Chuikyo Rep Interview 1 - JPA Vice President Warns against Rushed Dabate on Yakkasa, 2% Buffer Zone
  October 4, 2023

• BUSINESS Drug Makers Discontinue Sales of Alesion Dry Syrup, Generic Versions
  October 3, 2023

• REGULATORY As Copay Debate Picks Up Steam, MHLW Floats 4 Ideas for Coverage Reform
  October 2, 2023

• REGULATORY Japan Seeking Solutions as Lab Monkey Shortage, Price Surge Threaten to Stymie Drug Development
  October 2, 2023

• REGULATORY Guidelines Should Urge Drug Makers to Explain Solo-Wholesaler Decisions: Panel Members
  September 29, 2023

• REGULATORY As Chuikyo Begins Pricing Debate of Leqembi, Panelists Urge Safety, Fair Access
  September 28, 2023

• REGULATORY Japan Agrees to Buy Extra 10 Million Doses of Pfizer COVID Vaccine
  September 27, 2023

• BUSINESS Regeneron to Make Japan Debut with Dupixent Copromotion
  September 27, 2023

• REGULATORY Leqembi Subject to Cost Control Rule for Potential Big Sellers, MHLW Still Set to Meet Listing Deadline
  September 26, 2023

• REGULATORY Japan Approves Eisai/Biogen’s Alzheimer’s Drug Leqembi
  September 25, 2023

• ACADEMIA Academic Society Condemns Off-Label Use of GLP-1 Diabetes Drugs as Shipment Curbs Persist
  September 25, 2023

• BUSINESS LTL Pharma Sees “G1” LLP Price Cuts as Business Opportunity: President
  September 22, 2023

• REGULATORY Sitagliptin Increases Cancer Risk in 1 in 115,000 People with Current Global Impurity Limit: Makers
  September 22, 2023

• BUSINESS Lecanemab to Serve as Gamechanger in Science, Treatments Set to Start by Year-End: Biogen Japan Chief
  September 21, 2023

• REGULATORY Pharma Groups Stand in Unity to Push Reward for Innovation, Price Maintenance
  September 21, 2023

• REGULATORY MHLW Proposes Curbing Entries of Generic Makers That Threaten Stable Supplies
  September 20, 2023

• REGULATORY Japan to End Use of Original COVID Vaccine, Previous Omicron Jabs
  September 20, 2023

• ORGANIZATION JPMA Embarking on Creation of One-Stop Platform for Rare Disease Trial Info
  September 19, 2023

• REGULATORY Japan to Require Out-of-Pocket Cost for COVID Drugs from October
  September 19, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 53
• 54
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• …
• Next ›
• 最終 »